{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Catheter Precision, Inc. overvalued or undervalued?
As of August 15, 2022, Catheter Precision, Inc. is considered overvalued with a valuation grade of "does not qualify" due to negative earnings, poor performance metrics, and a one-year stock return of -95.54%, significantly underperforming compared to its peers and the S&P 500.
Is Catheter Precision, Inc. technically bullish or bearish?
As of June 17, 2025, the technical trend is mildly bearish, supported by bearish daily moving averages and KST readings, despite some mixed signals from the MACD and RSI.
What does Catheter Precision, Inc. do?
Catheter Precision, Inc. is a micro-cap medical device company that develops excimer lasers for treating dermatological and vascular diseases. As of March 2025, it reported net sales of $0 million and a net loss of $4 million, with a market cap of $4.19 million.
How big is Catheter Precision, Inc.?
As of Jun 18, Catheter Precision, Inc. has a market capitalization of 4.19 million, with net sales of 0.48 million and a net profit of -18.01 million over the latest four quarters. The company reported shareholder's funds of 11.76 million and total assets of 27.77 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
